Table 5. Antibiotic resistance pattern of bacteria isolated from VAP patients.
Drugs | A. baumannii (n = 55) | P. aeruginosa (n = 45) | K. pneumoniae (n = 45) | E. coli (n = 12) |
---|---|---|---|---|
Ampicillin | - | - | - | 100 |
Amoxy-clavulanic acid | - | 91.8 | 91.7 | |
Amikacin | 84.8 | 48.9 | 78.4 | 41.7 |
Tobramycin | 80.4 | 75.6 | 88.2 | 33.3 |
Gentamycin | 88 | 82.2 | 80.4 | 36.4 |
Ciprofloxacin | 90.2 | 46.7 | 96.1 | 91.7 |
Levofloxacin | 95.6 | 91.4 | 92.2 | 83.3 |
Aztreonam | - | 50 | 90 | 75 |
Ceftriaxone | 96.7 | - | 93.8 | 90 |
Cefoxitin | - | - | 93.8 | 90 |
Cefazolin | - | - | 100 | 100 |
Ceftazidime | - | 62.1 | - | - |
Piperacillin-tazobactam | 66.3 | 53.3 | 92.2 | 66.7 |
Imipenem | 85.9 | 57.8 | 66.7 | 50 |
Meropenem | 65.2 | 48.9 | 70.6 | 50 |
Ertapenem | - | - | 56 | 40 |
Colistin | 0 | 0 | 0 | 0 |
Tigecycline | 0 | 0 | 0 | 0 |